Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Legislation requiring healthcare professionals assess a woman for postpartum depression made it over the first hurdles last ...

Sooma Medical has received the approval of an investigational device exemption (IDE) from the US Food and Drug Administration ...

Over 30 million Americans take antidepressants. Researchers found four specific types with ties to cognition loss later in life.

Sooma Oy secured U.S. FDA investigational device exemption approval to initiate a pivotal study of its transcranial direct ...

An abundance of data show that SSRIs, a class of drugs commonly used as antidepressants, are effective, though, like any drug, they have risks.

Sooma announced that it received FDA investigational device exemption (IDE) for its transcranial direct current stimulation ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

This summary highlights key global health developments, including J&J halting studies of a depression drug due to low ...

Analysts say the decision is a “big blow” to a once-promising class of brain therapies that include’s J&J’s aticaprant and a ...

Analysts do not believe the Phase III stumble for aticaprant will derail J&J’s broader neuroscience strategy, particularly ...

Johnson & Johnson discontinues aticaprant's Phase 3 trial but explores future options. Another depression drug Spravato sales hit $1.01 billion ...